| Financial Year |
March 31 2023 |
| Monetary Funds |
121,336,501.88 |
| Held-for-trading Financial Assets |
135,438,337.33 |
| Notes Receivable |
2,375,286.41 |
| Accounts Receivable |
218,937,964.53 |
| Advances to Suppliers |
7,111,534.40 |
| Other Receivables |
4,943,432.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
208,416,430.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,591,314.17 |
| Total Current Assets |
724,243,198.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
310,056,571.33 |
| Under-construction Projects |
120,500,519.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
77,308,449.66 |
| R&D expenses |
-- |
| Goodwill |
68,609,652.26 |
| Long-Term Deferred and Prepaid Expenses |
1,151,240.63 |
| Deferred Income Tax Assets |
10,568,176.20 |
| Other Non-Current Assets |
2,708,421.03 |
| Sub-Total of Non-Current Assets |
603,657,562.76 |
| Total Assets |
1,327,900,761.43 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,884,359.33 |
| Accounts Payable |
123,438,288.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,201,650.85 |
| Taxes Payable |
14,350,726.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,187,860.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,637,464.45 |
| Other Current Liabilities |
558,001.23 |
| Sub-Total of Current Liabilities |
283,087,258.98 |
| Long-term Loans |
34,849,413.68 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,135,769.19 |
| Deferred Income Tax Liabilities |
12,590,295.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
71,347,118.57 |
| Total Liabilities |
354,434,377.55 |
| Paid-In Capital(Or Share Stock) |
230,000,000.00 |
| Capital Surplus |
395,027,937.05 |
| Surplus Reserve |
35,142,563.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
311,975,324.60 |
| Minority Stockholder's Interest |
7,994,807.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
965,471,576.86 |
| Owner's Equity（Stockholder's Equity） |
973,466,383.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,327,900,761.43 |
